Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00610792
Recruitment Status : Withdrawn (Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.)
First Posted : February 8, 2008
Last Update Posted : July 14, 2009
Information provided by:
Millennium Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : September 2009
  Study Completion Date : No date given